• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ATLN:VX

85.300 CHF 4.000 4.92%

As of 09:02:53 ET on 04/16/2014.

Snapshot for Actelion Ltd (ATLN)

Open: 82.400 Day's Range: 82.250 - 85.450 Volume: 315,846
Previous Close: 81.300 52wk Range: 50.741 - 93.450 1-Yr Rtn: +60.10%

Stock Chart for ATLN

No chart data available.
  • ATLN:VX 85.350
  • 1D
  • 1M
  • 1Y
81.300
Interactive ATLN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATLN

Current P/E Ratio (ttm) 20.7654
Estimated P/E(12/2014) 19.0573
Relative P/E vs. SMI 1.1140
Earnings Per Share (CHF) (ttm) 4.0500
Est. EPS (CHF) (12/2014) 4.4130
Est. PEG Ratio 1.9322
Market Cap (M CHF) 10,115.21
Shares Outstanding (M) 120.28
30 Day Average Volume 490,625
Price/Book (mrq) 6.0067
Price/Sale (ttm) 5.3353
Dividend Indicated Gross Yield 1.43%
Cash Dividend (CHF) 1.2000
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 04/17/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATLN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for ATLN

Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.

Jean-Paul ClozelCEO/Co-FounderAndre C MullerChief Financial Officer
Otto SchwarzExec VP/COONicholas FrancoVP/Chief Bus Dev Officer
More Company Profile & Key Executives for ATLN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil